These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36240332)

  • 1. Recommendations for the implementation of genetic testing for metastatic prostate cancer patients in Canada.
    Selvarajah S; Schrader KA; Kolinsky MP; Rendon RA; El Hallani S; Fleshner NE; Hotte SJ; Lorentz J; Panabaker K; Perrier R; Pouliot F; Spatz A; Yip S; Chi KN
    Can Urol Assoc J; 2022 Oct; 16(10):321-332. PubMed ID: 36240332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer.
    Vergote I; González-Martín A; Ray-Coquard I; Harter P; Colombo N; Pujol P; Lorusso D; Mirza MR; Brasiuniene B; Madry R; Brenton JD; Ausems MGEM; Büttner R; Lambrechts D;
    Ann Oncol; 2022 Mar; 33(3):276-287. PubMed ID: 34861371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.
    Paller CJ; Antonarakis ES; Beer TM; Borno HT; Carlo MI; George DJ; Graff JN; Gupta S; Heath EI; Higano CS; McKay RR; Morgans AK; Patnaik A; Petrylak DP; Rettig MB; Ryan CJ; Taplin ME; Whang YE; Vinson J; Cheng HH; Giri VN;
    Clin Genitourin Cancer; 2019 Aug; 17(4):275-282.e1. PubMed ID: 31171481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge of genetic testing for hereditary kidney cancer in Canada is lacking: The results of the Canadian national hereditary kidney cancer needs assessment survey.
    Violette PD; Kamel-Reid S; Graham GE; Reaume MN; Jewett MA; Care M; Basiuk J; Pautler SE
    Can Urol Assoc J; 2014 Nov; 8(11-12):E832-40. PubMed ID: 25485012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical application of genome-wide sequencing for monogenic diseases in Canada: Position Statement of the Canadian College of Medical Geneticists.
    Boycott K; Hartley T; Adam S; Bernier F; Chong K; Fernandez BA; Friedman JM; Geraghty MT; Hume S; Knoppers BM; Laberge AM; Majewski J; Mendoza-Londono R; Meyn MS; Michaud JL; Nelson TN; Richer J; Sadikovic B; Skidmore DL; Stockley T; Taylor S; van Karnebeek C; Zawati MH; Lauzon J; Armour CM;
    J Med Genet; 2015 Jul; 52(7):431-7. PubMed ID: 25951830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
    Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
    J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer.
    Gonzalez D; Mateo J; Stenzinger A; Rojo F; Shiller M; Wyatt AW; Penault-Llorca F; Gomella LG; Eeles R; Bjartell A
    J Pathol Clin Res; 2021 Jul; 7(4):311-325. PubMed ID: 33630412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Impact of germline BRCA2 and CHEK2 mutations on time to castration resistance in patients with metastatic hormone-nave prostate cancer].
    Matveev VB; Kirichek AA; Filippova MG; Savinkova AV; Khalmurzaev OA; Lyubchenko LN
    Urologiia; 2019 Dec; (5):79-85. PubMed ID: 31808637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic testing for homologous recombination repair (HRR) in metastatic castration-resistant prostate cancer (mCRPC): challenges and solutions.
    Scott RJ; Mehta A; Macedo GS; Borisov PS; Kanesvaran R; El Metnawy W
    Oncotarget; 2021 Aug; 12(16):1600-1614. PubMed ID: 34381565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolving Intersection Between Inherited Cancer Genetics and Therapeutic Clinical Trials in Prostate Cancer: A White Paper From the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.
    Carlo MI; Giri VN; Paller CJ; Abida W; Alumkal JJ; Beer TM; Beltran H; George DJ; Heath EI; Higano CS; McKay RR; Morgans AK; Patnaik A; Ryan CJ; Schaeffer EM; Stadler WM; Taplin ME; Kauff ND; Vinson J; Antonarakis ES; Cheng HH
    JCO Precis Oncol; 2018; 2018():. PubMed ID: 30761386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring conceptual and theoretical frameworks for nurse practitioner education: a scoping review protocol.
    Wilson R; Godfrey CM; Sears K; Medves J; Ross-White A; Lambert N
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):146-55. PubMed ID: 26571290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world homologous recombination repair mutation testing in metastatic castration-resistant prostate cancer in the USA, Europe and Japan.
    Leith A; Ribbands A; Kim J; Last M; Barlow S; Yang L; Ghate SR
    Future Oncol; 2022 Mar; 18(8):937-951. PubMed ID: 35043687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.
    Giri VN; Knudsen KE; Kelly WK; Cheng HH; Cooney KA; Cookson MS; Dahut W; Weissman S; Soule HR; Petrylak DP; Dicker AP; AlDubayan SH; Toland AE; Pritchard CC; Pettaway CA; Daly MB; Mohler JL; Parsons JK; Carroll PR; Pilarski R; Blanco A; Woodson A; Rahm A; Taplin ME; Polascik TJ; Helfand BT; Hyatt C; Morgans AK; Feng F; Mullane M; Powers J; Concepcion R; Lin DW; Wender R; Mark JR; Costello A; Burnett AL; Sartor O; Isaacs WB; Xu J; Weitzel J; Andriole GL; Beltran H; Briganti A; Byrne L; Calvaresi A; Chandrasekar T; Chen DYT; Den RB; Dobi A; Crawford ED; Eastham J; Eggener S; Freedman ML; Garnick M; Gomella PT; Handley N; Hurwitz MD; Izes J; Karnes RJ; Lallas C; Languino L; Loeb S; Lopez AM; Loughlin KR; Lu-Yao G; Malkowicz SB; Mann M; Mille P; Miner MM; Morgan T; Moreno J; Mucci L; Myers RE; Nielsen SM; O'Neil B; Pinover W; Pinto P; Poage W; Raj GV; Rebbeck TR; Ryan C; Sandler H; Schiewer M; Scott EMD; Szymaniak B; Tester W; Trabulsi EJ; Vapiwala N; Yu EY; Zeigler-Johnson C; Gomella LG
    J Clin Oncol; 2020 Aug; 38(24):2798-2811. PubMed ID: 32516092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of radical prostatectomy in metastatic prostate cancer: A review.
    Metcalfe MJ; Smaldone MC; Lin DW; Aparicio AM; Chapin BF
    Urol Oncol; 2017 Apr; 35(4):125-134. PubMed ID: 28190749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical Cancer Genetics: A guide for the pathologist].
    Basset N; Desseignés C; Boucher C; Coulet F; Benusiglio PR
    Ann Pathol; 2020 Apr; 40(2):63-69. PubMed ID: 32046877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practice guideline: joint CCMG-SOGC recommendations for the use of chromosomal microarray analysis for prenatal diagnosis and assessment of fetal loss in Canada.
    Armour CM; Dougan SD; Brock JA; Chari R; Chodirker BN; DeBie I; Evans JA; Gibson WT; Kolomietz E; Nelson TN; Tihy F; Thomas MA; Stavropoulos DJ;
    J Med Genet; 2018 Apr; 55(4):215-221. PubMed ID: 29496978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.